| Melissa Mafiah, MD | |
|
17000 Hubbard Dr Ste 800, Dearborn, MI 48126-4205 | |
| (313) 240-7595 | |
| (313) 240-7599 |
| Full Name | Melissa Mafiah |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 10 Years |
| Location | 17000 Hubbard Dr Ste 800, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568857605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 4351043073 (Michigan) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 4301117377 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital - Dearborn | Dearborn, MI | Hospital |
| Beaumont Hospital - Taylor | Taylor, MI | Hospital |
| Beaumont Hospital - Trenton | Trenton, MI | Hospital |
| Beaumont Hospital - Wayne | Wayne, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on today, Sept. 12.
Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).
The number of teenagers smoking remains worryingly high, with girls twice as likely as boys to take it up, according to ESRC-sponsored research tracking the habits of a large group of youngsters over the past six years.
Experts from the London School of Hygiene & Tropical Medicine today comment on the results of a malaria vaccine trial.
Maryse Lebrun, Research Director at Inserm, and her fellow researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques, have characterised a protein complex that allows the agents that cause malaria and toxoplasmosis to infect host cells.
› Verified 4 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on today, Sept. 12.
Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).
The number of teenagers smoking remains worryingly high, with girls twice as likely as boys to take it up, according to ESRC-sponsored research tracking the habits of a large group of youngsters over the past six years.
Experts from the London School of Hygiene & Tropical Medicine today comment on the results of a malaria vaccine trial.
Maryse Lebrun, Research Director at Inserm, and her fellow researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques, have characterised a protein complex that allows the agents that cause malaria and toxoplasmosis to infect host cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Mafiah, MD 26901 Beaumont Blvd # 3d, Southfield, MI 48033-3849 Ph: (947) 522-1952 | Melissa Mafiah, MD 17000 Hubbard Dr Ste 800, Dearborn, MI 48126-4205 Ph: (313) 240-7595 |
News Archive
Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on today, Sept. 12.
Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).
The number of teenagers smoking remains worryingly high, with girls twice as likely as boys to take it up, according to ESRC-sponsored research tracking the habits of a large group of youngsters over the past six years.
Experts from the London School of Hygiene & Tropical Medicine today comment on the results of a malaria vaccine trial.
Maryse Lebrun, Research Director at Inserm, and her fellow researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques, have characterised a protein complex that allows the agents that cause malaria and toxoplasmosis to infect host cells.
› Verified 4 days ago
Hi Joo Kim, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 17000 Hubbard Dr, Suite 800, Dearborn, MI 48126 Phone: 313-240-7595 Fax: 313-240-7599 | |
Miss Janice Chavez, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4945 Schaefer Rd, Dearborn, MI 48126 Phone: 313-581-0744 | |
Renee Talaat Ishak Labib, RPT, CLT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 5445 Oakman Blvd, Dearborn, MI 48126 Phone: 313-584-4625 Fax: 313-584-5676 | |
Dr. Riley M Smith, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Ste 411, Dearborn, MI 48124 Phone: 313-438-7373 Fax: 313-438-7375 | |
Matthew Pierce, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2552 Monroe St, Dearborn, MI 48124 Phone: 313-278-7800 | |
Dr. Melda Luzadas, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 15120 Michigan Ave, Dearborn, MI 48126 Phone: 313-582-1911 Fax: 313-582-8627 | |
Nicole Mokanyk, LPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 15101 Ford Rd, Dearborn, MI 48126 Phone: 877-660-1807 |